MedPath

Pharmacokinetics of high dose Ropivacaine with and without epinephrine for combined femoral and sciatic nerve block in lower extremity surgery. A pilot study.

Phase 4
Conditions
orthopaedic surgery of the lower extremity
10005944
Registration Number
NL-OMON33042
Lead Sponsor
Sint Maartenskliniek
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

- Patients >= 18 years, <= 60 years
- Body Weight >= 70 kg
- ASA classification I - III
- Patients undergoing combined femoral and sciatic nerve block for lower extremity orthopaedic surgery
- Who will be admitted for at least 48 hours
- Written informed consent

Exclusion Criteria

- Contra-indications for regional anesthesia (infection at the injection site, coagulopathy)
- Known hypersensitivity to amide-type local anesthetics
- Known history of peripheral neuropathy
- Known hepatic or renal insufficiency
- Use of fluvoxamine, ciprofloxacin, ketoconazole, erythromycin, clarithromycin, itraconazole, or rifampicin because of their effect on ropivacaine clearance.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Mean unbound and bound peak plasma concentration (Cmax) of ropivacaine with<br /><br>and without<br /><br>epinephrine<br /><br>2. Mean time to unbound and bound peak plasma concentration (Tmax) of<br /><br>ropivacaine with and<br /><br>without epinephrine<br /><br>3. Range of duration (width) of Cmax after single shot combined femoral and<br /><br>sciatic nerve block with<br /><br>and without epinephrine<br /><br>4. Range of apparent half-life of ropivacaine with and without epinephrine in<br /><br>combined femoral and<br /><br>sciatic nerve block (T*).<br /><br>5. Efficacy of the sensory blockade with and without epinephrine.<br /><br>6. Duration of the sensory blockade with and without epinephrine.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>age, length, weight and gender<br /><br>possible complications or side effects</p><br>
© Copyright 2025. All Rights Reserved by MedPath